{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T19:27:15Z","timestamp":1659986835595},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.mehy.2013.11.025","type":"journal-article","created":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T12:00:53Z","timestamp":1385899253000},"page":"159-162","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A multimodal Darwinian strategy for alleviating the atherosclerosis pandemic"],"prefix":"10.1016","volume":"82","author":[{"given":"Geetha","family":"Mathew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magith","family":"Thambi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.K.","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2013.11.025_b0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ajcn.81.2.341","article-title":"Origins and evolution of the Western diet: health implications for the 21st century","volume":"81","author":"Cordain","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.mehy.2013.11.025_b0010","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.93.10.1777","article-title":"Insulin resistance and atherosclerosis common roots for two common diseases?","volume":"93","author":"Taegtmeyer","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2013.11.025_b0015","doi-asserted-by":"crossref","DOI":"10.4061\/2010\/654078","article-title":"Gene\/environment interaction in atherosclerosis: an example of clinical medicine as seen from the evolutionary perspective","author":"Mertens","year":"2010","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.mehy.2013.11.025_b0020","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1073\/pnas.0906198106","article-title":"Evolution and public health","volume":"107","author":"Omenn","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2013.11.025_b0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/HYPERTENSIONAHA.111.187757","article-title":"Effects of hunter-gatherer subsistence mode on arterial distensibility in Cameroonian pygmies","volume":"60","author":"Lemogoum","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2013.11.025_b0030","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(13)60598-X","article-title":"Atherosclerosis across 4000years of human history: the Horus study of four ancient populations","volume":"381","author":"Thompson","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2013.11.025_b0035","doi-asserted-by":"crossref","unstructured":"Marchant J. Mummies reveal that clogged arteries plagued the ancient world. <http:\/\/www.nature.com\/news\/mummies-reveal-that-clogged-arteries-plagued-the-ancient-world-1.12568>. Nature News. 11 March 2013 [accessed on 06.08.13].","DOI":"10.1038\/nature.2013.12568"},{"key":"10.1016\/j.mehy.2013.11.025_b0040","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.mehy.2004.09.028","article-title":"Can worms defend our hearts? Chronic helminthic infections may attenuate the development of cardiovascular diseases","volume":"64","author":"Magen","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2013.11.025_b0045","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nri2415","article-title":"The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models","volume":"8","author":"Weber","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mehy.2013.11.025_b0050","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2013.11.025_b0055","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1067\/mai.2003.172","article-title":"Hygiene hypothesis: fact or fiction?","volume":"111","author":"Liu","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mehy.2013.11.025_b0060","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cell.2010.03.004","article-title":"Asthma and allergic inflammation","volume":"140","author":"Locksley","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.mehy.2013.11.025_b0065","doi-asserted-by":"crossref","first-page":"428593","DOI":"10.1155\/2010\/428593","article-title":"Immunity against helminths: interactions with the host and the intercurrent infections","volume":"2010","author":"Moreau","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.mehy.2013.11.025_b0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.parint.2009.02.001","article-title":"Helminths and our immune system: friend or foe?","volume":"58","author":"Helmby","year":"2009","journal-title":"Parasitol Int"},{"key":"10.1016\/j.mehy.2013.11.025_b0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12664-011-0147-z","article-title":"Environmental factors associated with Crohn\u2019s disease in India\u2014there\u2019s more to it than meets the eye","volume":"30","author":"Dhar","year":"2011","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.mehy.2013.11.025_b0080","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1440-1746.2006.04471.x","article-title":"Rising incidence and prevalence of Crohn\u2019s disease in Asia: is it apparent or real?","volume":"21","author":"Makharia","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.mehy.2013.11.025_b0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2567.2008.03007.x","article-title":"Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis","volume":"126","author":"Rook","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.mehy.2013.11.025_b0090","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bmj.299.6710.1259","article-title":"Hay fever, hygiene, and household size","volume":"299","author":"Strachan","year":"1989","journal-title":"Br Med J"},{"key":"10.1016\/j.mehy.2013.11.025_b0095","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.4049\/jimmunol.1000116","article-title":"A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice","volume":"185","author":"Gao","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2013.11.025_b0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrcardio.2011.62","article-title":"Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets","volume":"8","author":"Lahoute","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.mehy.2013.11.025_b0105","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","article-title":"A tale of two diseases: atherosclerosis and rheumatoid arthritis","volume":"100","author":"Pasceri","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2013.11.025_b0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.atherosclerosis.2011.12.026","article-title":"Correlation of peripheral Th17 cells and Th17-associated cytokines to the severity of carotid artery plaque and its clinical implication","volume":"221","author":"Liu","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2013.11.025_b0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cyto.2009.09.007","article-title":"The Th17\/Treg functional imbalance during atherogenesis in ApoE(\u2212\/\u2212) mice","volume":"49","author":"Xie","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.mehy.2013.11.025_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpara.2013.04.008","article-title":"Chronic Opisthorchis felineus infection attenuates atherosclerosis \u2013 an autopsy study","author":"Magen","year":"2013","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.mehy.2013.11.025_b0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1745-6215-14-112","article-title":"Trichuris suis ova in relapsing\u2013remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial","volume":"14","author":"Rosche","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.mehy.2013.11.025_b0130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2249.2009.04064.x","article-title":"The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease","volume":"159","author":"Harnett","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.mehy.2013.11.025_b0135","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/j.1572-0241.2003.07660.x","article-title":"Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease helminthic therapy for IBD","volume":"98","author":"Summers","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mehy.2013.11.025_b0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00436-008-1297-5","article-title":"An update on the use of helminths to treat Crohn\u2019s and other autoimmunune diseases","volume":"104","author":"Reddy","year":"2009","journal-title":"Parasitol Res"},{"key":"10.1016\/j.mehy.2013.11.025_b0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.2007.00528.x","article-title":"The essential role of mast cells in orchestrating inflammation","volume":"217","author":"Kinet","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.mehy.2013.11.025_b0150","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1161\/CIRCULATIONAHA.107.698480","article-title":"Mast cells as mediators and modulators of atherogenesis","volume":"115","author":"Libby","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2013.11.025_b0155","doi-asserted-by":"crossref","first-page":"H2612","DOI":"10.1152\/ajpheart.00879.2011","article-title":"Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice","volume":"302","author":"Smith","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.mehy.2013.11.025_b0160","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1582-4934.2007.00052.x","article-title":"Mast cells in vulnerable atherosclerotic plaques \u2013 a view to a kill","volume":"11","author":"Lindstedt","year":"2007","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.mehy.2013.11.025_b0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-065X.2007.00515.x","article-title":"Mast cells: multipotent local effector cells in atherothrombosis","volume":"217","author":"Kovanen","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.mehy.2013.11.025_b0170","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ni.f.216","article-title":"New developments in mast cell biology","volume":"9","author":"Kalesnikoff","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mehy.2013.11.025_b0175","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.atherosclerosis.2013.05.025","article-title":"Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice","volume":"229","author":"Wang","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.mehy.2013.11.025_b0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0014-5793(95)01368-7","article-title":"5\u2032-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C\u03b1 and native bovine protein phosphatase-2Ac","volume":"377","author":"Davies","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mehy.2013.11.025_b0185","first-page":"35","article-title":"Targeting cell cycle regulators in the diagnosis and treatment of atherosclerosis and restenosis: emerging topics, current limitations and future directions","volume":"7","author":"Silvestre","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.mehy.2013.11.025_b0190","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.RES.0000185823.73556.06","article-title":"Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression","volume":"97","author":"Igata","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.mehy.2013.11.025_b0195","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1113\/jphysiol.2006.108324","article-title":"AMPK and cell proliferation \u2013 AMPK as a therapeutic target for atherosclerosis and cancer","volume":"547","author":"Motoshima","year":"2006","journal-title":"J Physiol"},{"key":"10.1016\/j.mehy.2013.11.025_b0200","doi-asserted-by":"crossref","first-page":"33499","DOI":"10.1074\/jbc.M110.159772","article-title":"Adenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice","volume":"285","author":"Li","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2013.11.025_b0205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-pharmtox-010611-134537","article-title":"AMPK and mTOR in cellular energy homeostasis and drug targets","volume":"52","author":"Inoki","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.mehy.2013.11.025_b0210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nri3198","article-title":"Regulation and function of mTOR signalling in T cell fate decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mehy.2013.11.025_b0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","article-title":"Regulation of immune responses by mTOR","volume":"30","author":"Powell","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.mehy.2013.11.025_b0220","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.bcp.2010.08.009","article-title":"AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis","volume":"80","author":"Bai","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2013.11.025_b0225","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.0000201938.78044.75","article-title":"Metformin inhibits proinflammatory responses and nuclear factor-\u03baB in human vascular wall cells","volume":"26","author":"Isoda","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.mehy.2013.11.025_b0230","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2337\/diabetes.54.4.1123","article-title":"Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism","volume":"54","author":"Gallo","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2013.11.025_b0235","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1758-5996-5-6","article-title":"Metformin: an old but still the best treatment for type 2 diabetes","volume":"5","author":"Rojas","year":"2013","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.mehy.2013.11.025_b0240","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/187153011796429844","article-title":"5\u2032-Adenosine monophosphate-activated protein kinase and the metabolic syndrome","volume":"11","author":"Mor","year":"2011","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.mehy.2013.11.025_b0245","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/138945011793591617","article-title":"Vitamin D in atherosclerosis, vascular disease, and endothelial function","volume":"12","author":"Brewer","year":"2011","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.mehy.2013.11.025_b0250","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.109.856070","article-title":"1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes","volume":"120","author":"Oh","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2013.11.025_b0255","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.2337\/db06-0391","article-title":"Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p85 the two sides of a coin","volume":"55","author":"Draznin","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2013.11.025_b0260","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/dmrr.873","article-title":"1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells","volume":"24","author":"Zhou","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.mehy.2013.11.025_b0265","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7643-8903-1","author":"Rook","year":"2009","journal-title":"The hygiene hypothesis and Darwinian medicine series: progress in inflammation research"},{"key":"10.1016\/j.mehy.2013.11.025_b0270","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3945\/jn.111.146050","article-title":"Reduction of body weight by dietary garlic is associated with an increase in uncoupling protein mRNA expression and activation of AMP-activated protein kinase in diet-induced obese mice","volume":"141","author":"Lee","year":"2011","journal-title":"J Nutr"},{"key":"10.1016\/j.mehy.2013.11.025_b0275","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbrc.2009.08.018","article-title":"Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells","volume":"388","author":"Kim","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2013.11.025_b0280","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jaci.2007.12.1160","article-title":"Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk","volume":"121","author":"Lee","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mehy.2013.11.025_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3945\/jn.108.102772","article-title":"Dietary curcumin and limonin suppress CD4+T-cell proliferation and interleukin-2 production in mice","volume":"139","author":"Kim","year":"2009","journal-title":"J Nutr"},{"key":"10.1016\/j.mehy.2013.11.025_b0290","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/157016109787354097","article-title":"Models to study atherosclerosis: a mechanistic insight","volume":"7","author":"Singh","year":"2009","journal-title":"Curr Vasc Pharmacol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713005549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713005549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T05:00:00Z","timestamp":1564894800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987713005549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0306987713005549"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2013.11.025","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multimodal Darwinian strategy for alleviating the atherosclerosis pandemic","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2013.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}